← FDA Drug Approvals (Drugs@FDA)
ELUCIREM
NDA · New Drug Application · Sponsor: GUERBET · Approved 2022-09-21
Drug application
- FDA Application #
NDA216986
- Application type
- New Drug Application
- Brand name
- ELUCIREM
- Generic name
- GADOPICLENOL
- Active ingredients
- GADOPICLENOL
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- GUERBET
- Manufacturer
- BRACCO DIAGNOSTICS INC
- First approval
- 2022-09-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown